Technology
Health
Biotechnology

Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022

$0.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-11.11%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can watch OTLKW and buy or sell other stocks, options, ETFs, and crypto commission-free!

About OTLKW

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. Read More It focuses on monoclonal antibodies, in the disease areas of immunology and oncology. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Cranbury, NJ.

Employees
Headquarters
Cranbury, New Jersey
Founded
2010
Market Cap
Price-Earnings Ratio
Dividend Yield
Average Volume
High Today
$0.16
Low Today
$0.151
Open Price
$0.151
Volume
4.02K
52 Week High
52 Week Low

Collections

Technology
Health
Biotechnology
Therapy
Medical
Biopharmaceutical
Pharmaceutical
2018 IPO
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.